Certara

About:

Certara is a pharmaceutical company that accelerates medicines with biosimulation software and technology.

Website: https://www.certara.com

Twitter/X: certara

Top Investors: Arsenal Capital Partners, Mubadala

Description:

Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Certara's end-to-end platform includes biosimulation, regulatory science, and market access solutions. It integrates its unique portfolio of software and technology-enabled services spanning discovery to post-approval.

Total Funding Amount:

$839M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Princeton, New Jersey, United States

Founded Date:

2008-01-01

Contact Email:

Support(AT)certara.com

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2023-08-29

IPO Status:

Public

© 2025 bioDAO.ai